25 results
CORRESP
CPHI
China Pharma Holdings, Inc.
8 Sep 23
Correspondence with SEC
12:00am
pharmaceutical product portfolio is comprised mainly of prescription drugs, our major sales targets are hospitals. As of December 31, 2022, we have 16 sales … decide or are required to conduct more high-throughput screening than expected against current or additional disease targets to develop additional
S-1/A
74b8o7q040w5wm7ko2n
29 Jul 08
IPO registration (amended)
12:00am
S-1
higwye
11 Jul 08
IPO registration
12:00am
8-K
EX-10.4
5p417w80b5dpwwrsh
28 May 08
Entry into a Material Definitive Agreement
12:00am